Anson Funds Management’s Bausch Health BHC Stock Holding History

Anson Funds Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-107,200	Closed	-$739K	–	232
2022 Q3	$739K	Buy	+107,200	New	+$745K	0.09%	175

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Anson Funds Management's BHC Position: Q3 2022 in Review

Anson Funds Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 100,000 shares — an estimated $695K sold.

Anson Funds Management first reported a position in BHC in Q2 2019 and held it in 5 quarters. The position peaked at $1.76M in Q2 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

Anson Funds Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
Anson Funds Management sold 100,000 Bausch Health shares in Q3 2022, an estimated $695K.
Anson Funds Management first reported a position in Bausch Health in Q2 2019 and held it in 5 quarters.
Anson Funds Management's Bausch Health position peaked at $1.76M in Q2 2021.
283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Anson Funds Management's 13F filing for Q3 2022, filed 15 Nov 2022.